From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA staff says Acadia's drug for Parkinson's disease psychosis is effective

from Reuters

U.S. Food and Drug Administration staff members said on Friday Acadia Pharmaceuticals Inc's drug to treat psychosis associated with Parkinson's disease was an effective treatment for the condition. The drug, Nuplazid, is a new chemical compound and could be the first drug specifically approved in the United States for Parkinson's disease psychosis. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063